With a market cap of $100.4 billion, CVS Well being Company (CVS) delivers a variety of providers by means of its Well being Care Advantages, Well being Providers, and Pharmacy & Shopper Wellness segments. It supplies insurance coverage merchandise, pharmacy profit administration, and retail pharmacy providers to people, employers, and authorities applications.
Shares of the Woonsocket, Rhode Island-based firm have underperformed the broader market over the previous 52 weeks. CVS inventory has elevated 21.1% over this timeframe, whereas the broader S&P 500 Index ($SPX) has gained 29.8%. As well as, CVS inventory has declined marginally on a YTD foundation, in comparison with SPX’s 4.8% return.
Extra Information from Barchart
Nonetheless, shares of the pharmacy chain and pharmacy advantages supervisor have outpaced the State Avenue Well being Care Choose Sector SPDR ETF’s (XLV) 4.3% rise over the previous 52 weeks.
Shares of CVS Well being fell marginally on Feb. 10 as This fall 2025 adjusted EPS declined to $1.09 and adjusted working earnings fell 4.8% year-over-year. Issues had been amplified by a pointy 45.3% drop in full-year working earnings, pushed by a $5.7 billion goodwill impairment cost and about $1.2 billion in litigation prices, which overshadowed document income of $402.1 billion. Moreover, the corporate lowered its 2026 money circulation from operations steerage to at the least $9 billion.
For the fiscal yr ending in December 2026, analysts anticipate CVS’ adjusted EPS to develop 5.8% year-over-year to $7.14. The corporate’s earnings shock historical past is promising. It beat the consensus estimates within the final 4 quarters.
Among the many 24 analysts protecting the inventory, the consensus ranking is a “Sturdy Purchase.” That’s based mostly on 20 “Sturdy Purchase” scores, two “Reasonable Buys,” and two “Holds.”
This configuration is barely extra bullish than three months in the past, with 19 “Sturdy Purchase” scores on the inventory.
On Apr. 15, Baird raised its worth goal on CVS Well being to $94 whereas sustaining an “Outperform” ranking.
The imply worth goal of $94.96, representing a premium of 21.2% to CVS’ present worth. The Avenue-high worth goal of $105 suggests a virtually 34% potential upside.
On the date of publication, Sohini Mondal didn’t have (both instantly or not directly) positions in any of the securities talked about on this article. All data and knowledge on this article is solely for informational functions. This text was initially revealed on Barchart.com
